Oct 17
2023
FutureRx Part D Stars Selected by Imperial Health Plans
FutureRx (FRx) announced today that its FRx cloud-based healthcare platform for health plans and pharmacy benefits managers (PBMs) will be implemented by Imperial Health Plan of California, Inc. to enhance medication adherence among its Medicare Advantage population. The health plan will leverage the platform’s Part D Stars module to automate business processes, enhance medication adherence, and improve Part D Star ratings.
“At Imperial Health Plan, our vision is to deliver clinically effective and sustainable value-based care that achieves exceptional outcomes, a significant aspect of which is ensuring medication adherence by our members,” said Dr. Paveljit Bindra, CEO, Imperial Health. “By automating and streamlining much of this high-touch, resource-intensive process, FRx Part D Stars will help our pharmacy team prioritize its outreach to focus on members who are most at-risk for adverse health events, supporting improved health outcomes and enhanced performance on CMS Star Adherence measures.”
The FRx Part D Stars modulesimplifies the complex process of tracking and improving CMS Part D Star ratings with actionable insights and data-driven recommendations that drive performance. It identifies those members who are not getting their prescribed medications, which can negatively impact the member’s health and a health plan’s Part D Stars rating, while reducing administrative burdens and enhancing member and provider satisfaction and retention. The FRx architecture allows for rapid implementation and corresponding market-leading speed-to-value.
“FRx platform is ideal for a rapidly growing health plan like Imperial Health Plan that prioritizes quality care and outcomes,” said Anil Kottoor, CEO, FutureRx. “We are excited for our FRx Part D Stars module to play a key role in helping Imperial achieve Imperial Health’s care quality and Star rating goals through the transformative power of cutting-edge technology, advanced analytics, and expert support.”